Skip to main content
. 2022 May 26;22(1):146–155. doi: 10.1111/jocd.15064

FIGURE 1.

FIGURE 1

Schedule of split‐face exploratory treatments and assessments from baseline screening and randomization of candidate women and first treatment session (T0) up to the last assessment visit after six months (T3)